Livemedia Home

Previous Events


Next Events

facebook_icon twitter_icon youtube_icon google_plus_icon instagram rss_icon
A+ | A-
GR | EN

 Login / Register to Livemedia



Forgot your password?

09/03/2017 Congresses | Video | 9th International Congress of Internal Medicine | H.Mattle | Patent foramen ovale in cryptogenic stroke: Closure, antiplatelets or anticoagulants?

 
106 VIEWS EXPANDCOLLAPSE

Share

24.089 total
8 live
106 video
10.484 photo
Views:

18:00-19:30 ROUND TABLE
Πρόεδροι: H.Mattle,K.Spengos
18:00-18:25 Patent foramen ovale in cryptogenic stroke: Closure, antiplatelets or anticoagulants?
H.Mattle
18:25-18:50 Optimal strategy for detection of atrial fibrillation in patients with cryptogenic stroke
M.Kohrmann
18:50-19:15 Acute treatment in patients with acute ischemic stroke treated with oral anticoagulants
G.Ntaios
19:15-19:30 Discussion


 
Sort by Date | Views

Watch On Demand: 9th International Congress of Internal Medicine

Dates: March 9-11, 2017
Venue: Hilton Athens Hotel,Athens, Greece
Organization: Institute of Internal Medicine & Hepatology, Larissa, Greece

Department of Medicine & Research Laboratory of Internal Medicine
University of Thessaly Medical School, Larissa, Greece

Director: Professor G.N. Dalekos

Under the auspices of: University of Thessaly Medical School, Larissa, Greece
Website: www.internalmedicine-uth.gr

For the program, please click here.

P. Mallis | ORAL PRESENTATIONS OP01-OP09 192
E, Sevim | ORAL PRESENTATIONS OP01-OP09 125
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 86
V. Papavasileiou | ORAL PRESENTATIONS OP01-OP09 118
R. Sivritepe | ORAL PRESENTATIONS OP01-OP09 144
G. Ntaios | ORAL PRESENTATIONS OP01-OP09 118
S. O. Serin | ORAL PRESENTATIONS OP01-OP09 81
G. Ntetskas | ORAL PRESENTATIONS OP01-OP09 88
R.Liberal | Importance of European registries... 79
C.Packard | Should we treat everyone above... 239
K.Hovingh | Familial hypercholesterolemia... 169
T.Pedersen | PCSK9 inhibition: What is hot... 140
M.Burnier | Pros 125
K. P. Makaritsis Cons 161
Discussion - Questions 83
682
J.Putaala | Stroke in the young 121
J.Ferro | Drug-induced stroke 126
D.Strbian | Can we predict thrombolysis-associated... 103
C.Weimar | Management of intracranial artery... 92
Gk. Katsifis | SATELLITE LECTURE Sponsored... 142
H.Mattle | Patent foramen ovale in cryptogenic... 106
G. N. Dalekos | Welcome 88
Vravefsi | OPENING CEREMONY 71
D.Sereni | Inaugural Lecture 70
M Papatheodoridi | ORAL PRESENTATIONS OP10-OP18 151
S. Savvanis | ORAL PRESENTATIONS OP10-OP18 68
V. Ligoyra | ORAL PRESENTATIONS OP10-OP18... 85
K. Azariadi | ORAL PRESENTATIONS OP10-OP18... 98
I. Mani | ORAL PRESENTATIONS OP10-OP18 98
S. Karatapanis | ORAL PRESENTATIONS OP10-OP18 66
P. Arvaniti | ORAL PRESENTATIONS OP10-OP18 99
A. Molyvdas | ORAL PRESENTATIONS OP10-OP18 96
T. Karaoulani | ORAL PRESENTATIONS OP10-OP18 76
H.Toplak | Epidemiology, definition and... 74
P.Nilsson | Obesity, impaired glucose metabolism... 95
V.Kotsis | Mechanisms of obesity induced... 104
J. Jordan | Novel drugs in the treatment... 103
H.Wedemeyer | Chronic hepatitis C: Challenges... 87
Q&A | ROUND TABLE 78
C.Yurdaydin | Chronic hepatitis delta: An... 85
L.Guillevin | Treatment of ANCA-associated... 103
M.Rizzo | Novel approaches to manage dyslipidaemia,... 148
M.Samson | Biological-targeted treatments... 82
P.Valensi | Silent myocardial ischaemia... 75
Y.Renaudineau | Primary Sjögren’s syndrome:... 81
D.Ziegler | Diabetic neuropathy: New developments... 86
Q & A | ROUND TABLE 91
M.Manoussakis | Axial spondyloarthritis... 84
N. Gatselis | SATELLITE LECTURE 89
M. Mela | SATELLITE LECTURE 74
K. Mimidis | SATELLITE LECTURE 63
Q & A | SATELLITE LECTURE 67
F.Menichetti | Choosing antibiotics in difficult... 245
G. N. Dalekos | SATELLITE SYMPOSIUM 148
N Sipsas | SATELLITE SYMPOSIUM 88
R.Pálsson | European Curriculum of Internal... 87
N.Montano | Choosing wisely: To be or not... 87
P.Mannucci | The role of EFIM publications... 82
G.Lip | Selecting the appropriate antithrombotic... 110
E. Rapti | SATELLITE SYMPOSIUM 1.072
M. Schina | SATELLITE SYMPOSIUM 68
M. Bosilkovski | ORAL PRESENTATIONS OP28-OP33 113
S. Thomson | ORAL PRESENTATIONS OP28-OP33 72
M. Grira | ORAL PRESENTATIONS OP28-OP33 148
J. A. Lopes | Definition, classification... 110
D.Menucci | The role of points of entry... 66
R.Pálsson | Acute kidney injury after abdominal... 80
T.Hofmann | The impact of the International... 73
Q & A | ROUND TABLE 63
D. Vergani | STATE OF THE ART LECTURE 67
H.van Buuren | Scientific and practical... 78
A.Floreani | PBC: Old and novel therapies 71
A.Parés | Variant syndromes: Classification... 61
G.Hirschfield | Deranged cholestatic enzymes... 63
M.Blank | Disease specific IVIG to treat... 67
N. Gatselis | SATELLITE LECTURE 82
M.Ekstedt | Steatosis and metabolic risk... 66
E.Tsochatzis | Non-invasive assessment of... 97
P.Montravers | Reducing the antifungal drugs... 58
Q.Anstee | NAFLD genetics 63
M.Akova | Fighting multi-drug resistant... 73
P.Mannucci | The coagulopathy of chronic... 60
Y.de Boer | Diagnostic evaluation of suspected... 94
A.Alexopoulou | Management and outcome of... 82
C.Marañón | Myeloid populations are altered... 55
G. Papatheodoridis - Current challenges in... 91
S. Manolakokpoulos - New possibilities for... 85
I. Goulis - New combination EBR/GZR: the... 64
I. Vlachogiannakos - Next generation DAAs:... 68
Q & A | SATELLITE SYMPOSIUM 59
A. Floreani | Interview 241
1:10
R. Liberal | Interview 78
1:13
Y. de Boer | Interview 66
0:20